Tabah, Alexis
Canadian Critical Care Trials Group
4 papers on CoChatORCID 0000-0003-3513-2778
Most cited papers
- Verified
A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit.
Tabah, A., Cotta, M. O., Garnacho-Montero, J., Schouten, J., Roberts, J. A., Lipman, J., Tacey, M., Timsit, J.-F., Leone, M., Zahar, J. R., et al. (2016) · Clinical Infectious Diseases
Antibiotic Use and ResistanceNosocomial Infections in ICU
Cited by 220
- Verified
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)
Tabah, A., Bassetti, M., Kollef, M. H., Zahar, J.-R., Paiva, J.-A., Timsit, J.-F., Roberts, J. A., Schouten, J., Giamarellou, H., Rello, J., et al. (2020) · Intensive Care Medicine
Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria
Cited by 191
- Verified
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: The DIANA study.
De Bus, L., Depuydt, P., Steen, J., Dhaese, S., De Smet, K., Tabah, A., Akova, M., Cotta, M. O., De Pascale, G., Dimopoulos, G., et al. (2020) · Intensive Care Medicine
Antibiotic Use and ResistanceNosocomial Infections in ICU
Cited by 114
- Verified
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials
The LOVIT-COVID Investigators, O. B. O. T. C. C. C. T. G., Florescu, S., Stanciu, D., Zaharia, M., Kosa, A., Codreanu, D., Fareed, K., Kidwai, A., Kaye, C., Coutts, A., et al. (2023) · JAMA
Vitamin C and Antioxidants ResearchCOVID-19 Clinical Research Studies
Cited by 55
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free